MANDEEP BAJAJ to Randomized Controlled Trials as Topic
This is a "connection" page, showing publications MANDEEP BAJAJ has written about Randomized Controlled Trials as Topic.
Connection Strength
0.170
-
Type 2 diabetes and cardiovascular disease: A metabolic overview of recent clinical trials. J Diabetes Complications. 2017 02; 31(2):291-294.
Score: 0.096
-
Exenatide: a GLP-1 receptor agonist as novel therapy for Type 2 diabetes mellitus. Expert Opin Pharmacother. 2006 Jun; 7(8):1055-64.
Score: 0.047
-
GLP-1 Receptor Agonists and Cardiovascular Disease: a Meta-Analysis of Recent Cardiac Outcome Trials. Cardiovasc Drugs Ther. 2018 02; 32(1):65-72.
Score: 0.026